2015年6月26日上午，芬兰科学院博士后研究员、赫尔辛基大学药物化学与技术部的Helder
Santos博士访问仿生工程与生物力学中心，并在生命学院308会议室为大家做了题为“针对个性化医疗的仿生纳米医学”的报告。报告谈及纳米治疗以及微流道技术的意义等内容，引出了其研究重点，即纳米生物材料包括应用于药物控释方面的纳米多孔硅/硅复合材料、脂质体和固体脂质纳米粒子等，总结了应用于给药控制,诊断和癌症治疗领域的生物材料发展。报告精炼，对中心许多不同课题成员均有启迪。
Santos博士为大家进行纳米医学报告
Dr.
Hélder A. Santos 简历：
Dr.
Hélder A. Santos is a physical chemist specialized in electrochemistry,
biological mimetic models and soft interfaces. In 2003, he obtained hisMSc in
Chemistry from the Department of Chemistry, University of Porto (Portugal). In
2007, he obtained his DSc in Chem. Eng. from the Laboratory of Physical
Chemistry and Electrochemistry, Helsinki University of Technology (Finland, now
named Aalto University). In 2007, Dr. Santos joined the University of Helsinki,
Division of Pharmaceutical Technology, as a Postdoctoral Fellow. In 2009, he was
appointed Academy of Finland Postdoctoral Research Fellow.
Currently, he is the an Adjunct Professor (Docent) in
Pharmaceutical Nanotechnology, anAcademy of Finland Research Fellow (Associate
Researcher) and Principal Investigator/Group Leader at the Division of
Pharmaceutical Chemistry and Technology, University of Helsinki.He is also the
Head of the Unit of Pharmaceutical Nanotechnology and Chemical Microsystems
(NAMI). In 2012, Dr. Santos received the ERC starting grant for 2013-2017 worth
of 1.5 M€.
My current
research interest is the developement and applications of biomaterials for
controlled drug delivery, diagnostics and cancer therapy, including inorganic
mesoporous silica/silicon particulate systems, liposomes, solid lipid
nanoparticles.
Chair and coordinator (2009-2012) of the courses Solid State Analysis of Pharmaceutics, Advance Seminars in
Pharmaceutical Technology and Laboratory Experience within a Research
Group.
